GAPDHP49

Across TCGA pan-cancer cohorts, GAPDHP49 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GAPDHP49’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where GAPDHP49 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GAPDHP49 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

STAD, KICH, and THCA are the cancer types where GAPDHP49 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GAPDHP49 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.181	.001	5	view →
KICH	All	All	−0.082	.001	4	view →
THCA	Female	All	−0.058	.001	2	view →
HNSC	Male	IV	+0.047	.003	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

GAPDHP49–STAD

Open the STAD breakdown →